Robert Chapman

Standard Chemotherapy Compared With High-Dose Chemoradiotherapy for Multiple Myeloma: Final Results of Phase III US Intergroup Trial S9321

Bart Barlogie, Robert A. Kyle, Kenneth C. Anderson et al. · Journal of Clinical Oncology · 2006 · 495 citations · Full text

Medicine, Hematology, Oncology +16

The Effects of Oncologist Implicit Racial Bias in Racially Discordant Oncology Interactions

Louis A. Penner, John F. Dovidio, Richard Gonzalez et al. · Journal of Clinical Oncology · 2016 · 343 citations · Full text

Social Sciences, Communication, Oncology +17

Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production11Abbreviations: CTLs, cytotoxic T lymphocytes; LAK cells, lymphokine activated killer cells; IL-2, interleukin-2; IFN-γ, interferon-gamma; TNF-α, tumor necrosis factor-α NF-κB, nuclear factor kappa B; Con A, concanavalin A; HBSS, Hanks’ balanced salt solution; DTT, dithiothreitol; PMSF, phenylmethylsulfonyl fluoride; RT-PCR, reverse transcription-polymerase chain reaction; LPS, lipopolysaccharide; and EMSA, electrophoretic mobility shift assay.

Xiaohua Gao, Yong Xu, Nalini Janakiraman et al. · Biochemical Pharmacology · 2001 · 248 citations

Life Sciences, Immunology, Pharmacology +17

Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: Comparison of 30-, 60-, and 90-mg dosages

Samuel R. Nussbaum, Jerry Younger, C. Vandepol et al. · The American Journal of Medicine · 1993 · 228 citations

Medicine, Pharmacology, Pharmacotherapy +5

Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid

P. Savvides, Govardhanan Nagaiah, Pierre Lavertu et al. · Thyroid · 2012 · 219 citations

Medicine, Oncology, Pharmacotherapy +17